These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 16505416

  • 1. Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.
    Oh DS, Troester MA, Usary J, Hu Z, He X, Fan C, Wu J, Carey LA, Perou CM.
    J Clin Oncol; 2006 Apr 10; 24(11):1656-64. PubMed ID: 16505416
    [Abstract] [Full Text] [Related]

  • 2. Progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.
    Liu S, Chia SK, Mehl E, Leung S, Rajput A, Cheang MC, Nielsen TO.
    Breast Cancer Res Treat; 2010 Jan 10; 119(1):53-61. PubMed ID: 19205877
    [Abstract] [Full Text] [Related]

  • 3. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G, Kalogeras KT, Wirtz RM, Grimani I, Zografos G, Gogas H, Stropp U, Pectasides D, Skarlos D, Hennig G, Samantas E, Bafaloukos D, Papakostas P, Kalofonos HP, Pavlidis N, Fountzilas G.
    Breast Cancer Res Treat; 2009 Jul 10; 116(1):131-43. PubMed ID: 18668363
    [Abstract] [Full Text] [Related]

  • 4. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
    Harigopal M, Heymann J, Ghosh S, Anagnostou V, Camp RL, Rimm DL.
    Breast Cancer Res Treat; 2009 May 10; 115(1):77-85. PubMed ID: 18521745
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Short-term outcome of primary operated early breast cancer by hormone and HER-2 receptors.
    Brouckaert O, Pintens S, Van Belle V, Van Huffel S, Camerlynck E, Amant F, Leunen K, Smeets A, Berteloot P, Van Limbergen E, Decock J, Hendrickx W, Weltens C, Van den Bogaert W, Vanden Bempt I, Drijkoningen M, Paridaens R, Wildiers H, Vergote I, Christiaens MR, Neven P.
    Breast Cancer Res Treat; 2009 May 10; 115(2):349-58. PubMed ID: 18629635
    [Abstract] [Full Text] [Related]

  • 9. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA.
    Breast Cancer Res; 2008 May 10; 10(5):R88. PubMed ID: 18928543
    [Abstract] [Full Text] [Related]

  • 10. The prognostic biomarkers HOXB13, IL17BR, and CHDH are regulated by estrogen in breast cancer.
    Wang Z, Dahiya S, Provencher H, Muir B, Carney E, Coser K, Shioda T, Ma XJ, Sgroi DC.
    Clin Cancer Res; 2007 Nov 01; 13(21):6327-34. PubMed ID: 17975144
    [Abstract] [Full Text] [Related]

  • 11. Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.
    Kok M, Koornstra RH, Margarido TC, Fles R, Armstrong NJ, Linn SC, Van't Veer LJ, Weigelt B.
    J Pathol; 2009 Jul 01; 218(3):316-26. PubMed ID: 19353633
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.
    Weisz A, Basile W, Scafoglio C, Altucci L, Bresciani F, Facchiano A, Sismondi P, Cicatiello L, De Bortoli M.
    J Cell Physiol; 2004 Sep 01; 200(3):440-50. PubMed ID: 15254972
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value.
    Voduc D, Cheang M, Nielsen T.
    Cancer Epidemiol Biomarkers Prev; 2008 Feb 01; 17(2):365-73. PubMed ID: 18268121
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
    Kok M, Linn SC, Van Laar RK, Jansen MP, van den Berg TM, Delahaye LJ, Glas AM, Peterse JL, Hauptmann M, Foekens JA, Klijn JG, Wessels LF, Van't Veer LJ, Berns EM.
    Breast Cancer Res Treat; 2009 Jan 01; 113(2):275-83. PubMed ID: 18311582
    [Abstract] [Full Text] [Related]

  • 19. The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer.
    Ma XJ, Hilsenbeck SG, Wang W, Ding L, Sgroi DC, Bender RA, Osborne CK, Allred DC, Erlander MG.
    J Clin Oncol; 2006 Oct 01; 24(28):4611-9. PubMed ID: 17008703
    [Abstract] [Full Text] [Related]

  • 20. 3-Dimensional microarray analysis of estrogen signal-related genes in breast cancer tissues.
    Matsumoto M, Sakamoto H, Yamaguchi Y, Seino Y, Takei H, Kurosumi M, Sasano H, Yaegashi N, Hayashi S.
    Anticancer Res; 2009 Oct 01; 29(10):3971-5. PubMed ID: 19846938
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.